Page last updated: 2024-10-28

haloperidol and Pulmonary Eosinophilia

haloperidol has been researched along with Pulmonary Eosinophilia in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleva, RM1
Aalbers, R1
Koëter, GH1
De Monchy, JG1

Other Studies

1 other study available for haloperidol and Pulmonary Eosinophilia

ArticleYear
Occupational asthma caused by a hardener containing an aliphatic and a cycloaliphatic diamine.
    The American review of respiratory disease, 1992, Volume: 145, Issue:5

    Topics: Adult; Asthma; Bronchoalveolar Lavage Fluid; Cyclohexylamines; Diamines; Epoxy Resins; Humans; Male;

1992